pause_circle_filledNot Yet Recruiting

Endometrial hyperplasia

A Study to Learn How Well Mirena Works as Compared to Oral Progestin in Nonatypical Endometrial Hyperplasia in Women who have started their periods

Trial purpose

Researchers are looking for a better way to treat women with nonatypical endometrial hyperplasia (NAEH).

Endometrial hyperplasia is a condition where the lining of the uterus (called the endometrium) becomes too thick. Nonatypical means that the condition is not cancerous. It is often caused by hormone imbalances in women. Symptoms can include abnormal vaginal bleeding or irregular periods. If this condition is not treated, then it may lead to cancer.

Currently, oral progestins (OP) which are progesterone (female hormone) capsules taken by mouth, are used to treat NAEH. However, there is still a need for other treatments due to unmet needs.

The study treatment, Mirena (also known as BAY 865028), is already available as a type of birth control device. It is inserted into the uterus where it gradually releases progesterone.

In this study, researchers want to find out if Mirena works for women with NAEH. They believe it can help by keeping hormone levels balanced in the body.

The main purpose of this study is to learn how well Mirena works compared to oral in NAEH in women who have started their periods.

For this, the researchers will compare the number of participants with benign endometrium after 6 months of treatment with Mirena or oral progestins.

The study participants will be randomly divided equally into one of two treatment groups. Based on their group, participants will receive Mirena, which is inserted into the uterus at the start of the study, or they will take progestins once daily by mouth for 6 months.

Each participant will be in the study for around 10 months with up to 5 visits to the study clinic/site.

Participants will visit the study clinic:
- once before the treatment starts
- 3 times with a gap of 3 months between the visits during the treatment
- then 1 more time after the treatment ends

During the study, the doctors and their study team will:
- check participant's health by performing tests such as blood and urine tests
- perform vaginal ultrasound and hysteroscopy. Hysteroscopy is a minor surgical procedure where a thin camera will be inserted into the womb to check for any abnormality. Sampling of the endometrial lining (cells in the womb) will be done with a thin tube at the same time.
- take samples of womb (endometrial) lining
- ask the participants questions about how they are feeling and what adverse events they are having

An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events, irrespective if they think it is related or not to the study treatment.

Key Participants Requirements

Sex

Female

Age

16 - N/A
  • - Post-menarchal women (≥ 16-years) at the time of signing the informed consent.
    - Women with histologically confirmed NAEH independent of their parity or menopausal status.
  • - Any diseases or conditions that might interfere with the conduct of the study or the interpretation of the results.
    - Congenital or acquired uterine or cervical anomaly including fibroids, or cervical stenosis that in the opinion of the investigator, would interfere with insertion and/or retention of the intrauterine system (i.e., if they distort the uterine cavity).
    - Use of any long-acting injectable sex-hormone preparations within 6 months prior to the start of study intervention, and /or short acting hormonal medication within 6 weeks prior to the start of study intervention.
    - Pregnancy
    - Participants with either known family or personal history of genetic predisposition to uterine, ovarian or colorectal cancers (e.g. Lynch syndrome).

Trial summary

Enrollment Goal
300
Trial Dates
June 2025 - October 2026
Phase
Phase 3
Could I Receive a placebo
No
Products
Mirena (Levonorgestrel IUS, BAY86-5028)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Not yet recruiting
Southern Clinical Research Associates | Metairie, LAMetairie, 70001, United States
Not yet recruiting
Unified Women's Clinical Research | Raleigh, NCRaleigh, 27607, United States
Not yet recruiting
Omni Fertility and Laser InstituteShreveport, 71118, United States
Not yet recruiting
Gynecologic Oncology AssociatesShreveport, 71103, United States
Not yet recruiting
Unified Women's Clinical ResearchWinston-Salem, 27103, United States
Not yet recruiting
Clinical Research PrimeIdaho Falls, 83404, United States
Not yet recruiting
Mesa Obstetricians and Gynecologists | Research DepartmentMesa, 85206, United States
Not yet recruiting
Affiliated Clinical Research, Inc. | Las Vegas, NVLas Vegas, 89113, United States
Not yet recruiting
Inova Fairfax Hospital - OBGYNFalls Church, 22042, United States
Not yet recruiting
Galen Obstetrics And Gynecology RidgesideChattanooga, 37404, United States
Not yet recruiting
Rutgers Robert Wood Johnson Medical SchoolNew Brunswick, 08901, United States
Not yet recruiting
Women's Health Alliance of MobileMobile, 36604, United States
Not yet recruiting
Cornerstone Clinic for WomenLittle Rock, 72205, United States
Not yet recruiting
Advances in Health, INC. | Houston, TXHouston, 77030, United States
Not yet recruiting
Physician Care Clinical Research LLC | Sarasota, FLSarasota, 34239, United States
Not yet recruiting
Women's Healthcare Associates, PAIdaho Falls, 83404, United States
Not yet recruiting
Discovery Clinical Trials - DallasDallas, 75231, United States
Not yet recruiting
Axia Women's HealthOaks, 19456, United States
Not yet recruiting
ClinOhio Research Services, LLC. | Columbus, OHColumbus, 43213, United States
Not yet recruiting
University of FloridaGainesville, 32608, United States
Not yet recruiting
University of California Davis Medical CenterSacramento, 95817, United States
Not yet recruiting
UT Health San Antonio - UT Health Medical Arts & Research Center (MARC)San Antonio, 78229-3931, United States
Not yet recruiting
Johns Hopkins Outpatient Center - Obstetrics and GynecologyBaltimore, 21287, United States
Not yet recruiting
South Texas Clinical ResearchCorpus Christi, 78404, United States
Not yet recruiting
McGill Family PracticePapillion, 68046, United States
Not yet recruiting
St. Dominic's Gynecology/OncologyJackson, 39216, United States
Not yet recruiting
Allen Clinical Research LLCGardena, 90247, United States
Not yet recruiting
Peking Union Medical College Hospital CAMSBeijing, 100730, China
Not yet recruiting
Jiangxi Maternal and Child Health HospitalNanchang, 330006, China
Not yet recruiting
Nanjing Medical University (NMU) - The Second Affiliated HospitalNanjing, 210011, China
Not yet recruiting
Chengdu Women & Children's Central HospitalChengdu, 610091, China
Not yet recruiting
Xiamen Maternity and Child Health Care HospitalXiamen, TBC, China
Not yet recruiting
Women's Hospital School of Medicine Zhejiang UniversityHangzhou, 310006, China
Not yet recruiting
Nanjing Maternity and Child Health Care HospitalNanjing, 210004, China
Not yet recruiting
Bosque Women's Care | Albuquerque, NMAlbuquerque, 87109, United States
Not yet recruiting
OB/GYN Associates of ErieErie, 16507, United States
Not yet recruiting
Piedmont HospitalAtlanta, 30309, United States
Not yet recruiting
Emerald Coast Clinical ResearchPanama City, 32405, United States
Not yet recruiting
The Woman's Place - Midlife HealthCharlottesville, 22903, United States
Not yet recruiting
Chongqing Maternal and Child Health Care HospitalChongqing, China
Not yet recruiting
Velvet Clinical ResearchBurbank, 91506, United States
Not yet recruiting
Office of Dr. Cindy Basinski, LLCNewburgh, 47630, United States
Not yet recruiting
Sweet Hope Research Specialty, Inc. | Hialeah, FLHialeah, 33016, United States
Not yet recruiting
McFarland ClinicAmes, 50010, United States
Not yet recruiting
Velocity Clinical Research - LafayetteLafayette, 70508, United States
Not yet recruiting
University of Alabama at BirminghamBirmingham, 35233, United States

Primary Outcome

  • Proportion of participants with Complete Resolution (CR) of NAEH
    Complete Resolution will be evaluated as benign endometrium.
    date_rangeTime Frame:
    At 6 months

Secondary Outcome

  • Recurrence of NAEH after CR
    Recurrence of NAEH on 3 months treatment free after CR at 6 months
    date_rangeTime Frame:
    At 3 months follow up after 6 months treatment
  • Progression after CR
    Endometrial hyperplasia with atypia or endometrial cancer after 3 months treatment free follow up after CR at 6 months
    date_rangeTime Frame:
    At 3 months follow up after 6 months treatment
  • Proportion of participants having hysterectomy
    date_rangeTime Frame:
    During treatment and 3 months follow up
  • Diagnosis of "benign endometrium"
    date_rangeTime Frame:
    At 6 months of treatment followed by 3 month treatment-free follow up
  • Number of participants with adverse events
    All AEs will be coded using the latest version prior to database lock of the Medical Dictionary for Regulatory Activities
    date_rangeTime Frame:
    From the signing of the informed consent form (ICF) up to 3 months after the last dose of study intervention

Trial design

A multi-center, open label, randomized parallel group study evaluating the proportion of post-menarchal women with complete resolution of nonatypical endometrial hyperplasia treated with Mirena or oral progestin for 6 months
Trial Type
Interventional
Intervention Type
Combination Product
Trial Purpose
Treatment
Allocation
Randomized
Blinding
N/A
Assignment
Parallel Assignment
Trial Arms
2